Cara Therapeutics Inc (CARA)
0.7919
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
0.7919
0.00 (0.00%)
After-Hours: 18:17
Cara Therapeutics Cash from Investing (Quarterly): -30.20M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.20M |
| September 30, 2023 | 23.16M |
| June 30, 2023 | 32.80M |
| March 31, 2023 | 17.71M |
| December 31, 2022 | 44.42M |
| September 30, 2022 | 21.18M |
| June 30, 2022 | 29.68M |
| March 31, 2022 | 33.43M |
| December 31, 2021 | -53.58M |
| September 30, 2021 | 14.43M |
| June 30, 2021 | 20.53M |
| March 31, 2021 | 13.87M |
| December 31, 2020 | -164.16M |
| September 30, 2020 | 39.54M |
| June 30, 2020 | 67.38M |
| March 31, 2020 | 36.96M |
| December 31, 2019 | 14.74M |
| September 30, 2019 | -96.88M |
| June 30, 2019 | 25.23M |
| March 31, 2019 | 26.40M |
| December 31, 2018 | -57.83M |
| September 30, 2018 | 5.454M |
| Date | Value |
|---|---|
| June 30, 2018 | -51.14M |
| March 31, 2018 | 20.69M |
| December 31, 2017 | 8.126M |
| September 30, 2017 | 12.08M |
| June 30, 2017 | -71.40M |
| March 31, 2017 | 14.70M |
| December 31, 2016 | 20.54M |
| September 30, 2016 | 14.78M |
| June 30, 2016 | 7.082M |
| March 31, 2016 | 2.614M |
| December 31, 2015 | -91.66M |
| September 30, 2015 | -0.001M |
| June 30, 2015 | -0.006M |
| March 31, 2015 | -0.006M |
| December 31, 2014 | -0.015M |
| September 30, 2014 | -0.021M |
| June 30, 2014 | -0.006M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.001M |
| September 30, 2013 | -0.004M |
| June 30, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-164.16M
Minimum
Dec 2020
67.38M
Maximum
Jun 2020
4.749M
Average
21.18M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Nektar Therapeutics | 17.38M |
| Stereotaxis Inc | 0.00 |
| Cerus Corp | 1.446M |
| Avid Bioservices Inc | -4.488M |
| Rigel Pharmaceuticals Inc | -6.874M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.37M |
| Cash from Financing (Quarterly) | 36.48M |
| Free Cash Flow | -94.45M |
| Free Cash Flow Per Share (Quarterly) | -0.3565 |
| Free Cash Flow to Equity (Quarterly) | -19.42M |
| Free Cash Flow Yield | -220.3% |